BAQSIMI Nasal Powder
Glucagon (Synthetic)
3mg/Dose
ELI LILLY AND COMPANY
| Pack size | 1 Nasal Device (1 Dose) |
|---|---|
| Dispensing mode | POM |
| Source | USA |
| Agent | PHARMATRADE |
| Retail Price | 495.00 AED |
Indications
BAQSIMI Nasal Powder is used for:
For treatment of severe hypoglycemia, also used in gastrointestinal imaging
Adult Dose
Child Dose
Renal Dose
Administration
Contra Indications
Precautions
Pregnancy-Lactation
Interactions
Adverse Effects
Side effects of Glucagon (Synthetic) :
Mechanism of Action
Glucagon binds the glucagon receptor, a G protein-coupled receptor located in the plasma membrane, which then initiates a dual signaling pathway using both adenylate cyclase activation and increased intracellular calcium. Adenylate cyclase manufactures cAMP (cyclic AMP), which activates protein kinase A (cAMP-dependent protein kinase). This enzyme, in turn, activates phosphorylase kinase, which, in turn, phosphorylates glycogen phosphorylase, converting into the active form called phosphorylase A. Phosphorylase A is the enzyme responsible for the release of glucose-1-phosphate from glycogen polymers. This yields glucose molecules to be released into the blood. Glucagon receptors are found in the liver, kidney, brain and pancreatic islet cells. The glucagon mediated signals lead to an increase in insulin excretion
Note
BAQSIMI 3mg/Dose Nasal Powder manufactured by ELI LILLY AND COMPANY. Its generic name is Glucagon (Synthetic). BAQSIMI is availble in United Arab Emirates.
Farmaco UAE drug index information on BAQSIMI Nasal Powder is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.